Brain processes in discounting: Consequences of adolescent methylphenidate exposure

Current Topics in Behavioral Neurosciences

Volumn 9, Issue , 2012, Pages 113-143

  Adriani, Walter ^a   Zoratto, Francesca ^a   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Delay discounting; Long term effects; Magnetic resonance; Preclinical models; Psychostimulants; Rats

Indexed keywords

CREATINE; DOPAMINE TRANSPORTER; METHYLPHENIDATE; SEROTONIN 7 RECEPTOR; CARRIER PROTEIN; CENTRAL STIMULANT AGENT;

ADOLESCENCE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN METABOLISM; CIRCADIAN RHYTHM; DELAY DISCOUNTING; DENDRITE; DEVELOPMENTAL DISORDER; DISEASE MODEL; DOPAMINERGIC SYSTEM; DRUG EXPOSURE; FOREBRAIN; GENE EXPRESSION; IMAGING; INSTRUMENTAL CONDITIONING; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RESPONSE TIME; RODENT MODEL; SELF CONTROL; SEROTONINERGIC SYSTEM; STRIATE CORTEX; VENTRAL STRIATUM; ADOLESCENT; ANIMAL; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; DRUG EFFECTS; GENETICS; HUMAN; INHIBITION (PSYCHOLOGY); METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; UPREGULATION;

ADOLESCENT; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; HUMANS; INHIBITION (PSYCHOLOGY); MEMBRANE TRANSPORT PROTEINS; METHYLPHENIDATE; UP-REGULATION;

EID: 84863496893     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2011_156     Document Type: Article

References (148)

1. Accardo P, Blondis TA (2001) What's all the fuss about Ritalin? J Pediatr 138:6-9
2. Adriani W, Laviola G (2004) Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav Pharmacol 15:341-352
3. Adriani W, Laviola G (2006) Delay aversion but preference for large and rare rewards in two choice tasks: implications for the measurement of self-control parameters. BMC Neurosci 7:52
4. Adriani W, Leo D, Greco D, Rea M, di Porzio U, Laviola G, Perrone-Capano C (2006) Methylphenidate administration to adolescent rats determines plastic changes on reward-related behavior and striatal gene expression. Neuropsychopharmacology 31:1946-1956
5. Adriani W, Canese R, Podo F, Laviola G (2007) 1H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence. Neurotoxicol Teratol 29:116-125
6. Adriani W, Boyer F, Gioiosa L, Macrì S, Dreyer JL, Laviola G (2009) Increased impulsive behavior and risk proneness following lentivirus-mediated dopamine transporter overexpression in rats' nucleus accumbens. Neuroscience 159:47-58
7. Adriani W, Boyer F, Leo D, Canese R, Podo F, Perrone-Capano C, Dreyer JL, Laviola G (2010a) Social withdrawal and gambling-like profile after lentiviral manipulation of DAT expression in the rat accumbens. Int J Neuropsychopharmacol 13:1329-42
8. Adriani W, Zoratto F, Romano E, Laviola G (2010b) Cognitive impulsivity in animal models: role of response time and reinforcing rate in delay intolerance with two-choice operant tasks. Neuropharmacology 58:694-701
9. Alexander GE, Crutcher MD, De Long MR (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 85:119-146
10. Altabella L, Strolin S, Villani N, Zoratto F, Canese R (2011) Magnetic resonance imaging and spectroscopy in the study in ADHD syndrome: a short review. Biophys Bioeng Lett 4:23-34
11. Ames A III (2000) CNS energy metabolism as related to function. Brain Res Rev 34:42-68
12. Andersen SL, Gazzara RA (1993) The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on spontaneous release. J Neurochem 61:2247-2255
13. Andersen SL, Thompson AT, Rutstein M, Hostetter JC, Teicher MH (2000) Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse 37:167-169
14. Andersen SL, Arvanitogiannis A, Pliakas AM, Le Blanc C, Carlezon WA Jr (2002) Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 5:13-14
15. Arnett J (1992) Reckless behavior in adolescence: a developmental perspective. Dev Rev 12:339-373
16. Arria AM, Wish ED (2006) Nonmedical use of prescription stimulant drugs among students. Pediatr Ann 35:565-571
17. Balleine BW, Delgado MR, Hikosaka O (2007) The role of the dorsal striatum in reward and decision-making. J Neurosci 27:8161-8165
18. Banerjee PS, Aston J, Khundakar AA, Zetterström TS (2009) Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate- early gene Arc in the juvenile and adult brain. Eur J Neurosci 29:465-476
19. Barkley RA, Fischer M, Smallish L, Fletcher K (2003) Does the treatment of attention-deficit/ hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 111:97-109
20. Bava S, Jacobus J, Mahmood O, Yang TT, Tapert SF (2010) Neurocognitive correlates of white matter quality in adolescent substance users. Brain Cogn 72:347-354
21. Berridge KC (2007) The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl) 191:391-431
22. Blakemore SJ (2008) The social brain in adolescence. Nat Rev 9:267-277
23. Bogle KE, Smith BH (2009) Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences. Curr Drug Abuse Rev 2:157-176
24. Bolanos CA, Glatt SJ, Jackson D (1998) Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Brain Res 111:25-33
25. Bolanos CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ (2003) Methylphenidate treatment during pre-and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54:1317-1329
26. Bonaventure P, Kelly L, Aluisio L, Shelton J, Lord B, Galici R, Miller K, Atack J, Lovenberg TW, Dugovic C (2007) Selective blockade of 5-hydroxytryptamine (5-HT) 7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J Pharmacol Exp Ther 321:690-698
27. Botly LC, Burton CL, Rizos Z, Fletcher PJ (2008) Characterization of methylphenidate selfadministration and reinstatement in the rat. Psychopharmacology (Berl) 199:55-66
28. Brandon CL, Steiner H (2003) Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. Eur J Neurosci 18:1584-1592
29. Brandon CL, Marinelli M, Baker LK, White FJ (2001) Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25:651-661
30. Brandon CL, Marinelli M, White FJ (2003) Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons. Biol Psychiatry 54:1338-1344
31. Brenhouse HC, Andersen SL (2011) Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes. Neurosci Biobehav Rev 35:1687-703
32. Britton GB, Segan AT, Sejour J, Mancebo SE (2007) Early exposure to methylphenidate increases fear responses in an aversive context in adult rats. Dev Psychobiol 49:265-75
33. Burton CL, Nobrega JN, Fletcher PJ (2010) The effects of adolescent methylphenidate selfadministration on responding for a conditioned reward, amphetamine-induced locomotor activity, and neuronal activation. Psychopharmacology (Berl) 208:455-68
34. Canales JJ (2005) Stimulant-induced adaptations in neostriatal matrix and striosome systems: transiting from instrumental responding to habitual behavior in drug addiction. Neurobiol Learn Mem 83:93-103
35. Canese R, Adriani W, Marco EM, De Pasquale F, Lorenzini P, De Luca N, Fabi F, Podo F, Laviola G (2009) Peculiar response to methylphenidate in adolescent compared to adult rats: a phMRI study. Psychopharmacology (Berl) 203:143-53
36. Cardinal RN, Winstanley CA, Robbins TW, Everitt BJ (2004) Limbic corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci 1021:33-50
37. Carlezon WA Jr, Mague SD, Andersen SL (2003) Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54:1330-1337
38. Casey BJ, Jones RM, Hare TA (2008) The adolescent brain. Ann N Y Acad Sci 1124:111-126
39. Challman TD, Lipsky JJ (2000) Methylphenidate: its pharmacology and uses. Mayo Clin Proc 75:711-721
40. Chambers RA, Potenza MN (2003) Neurodevelopment, impulsivity, and adolescent gambling. J Gambl Stud 19:53-84
41. Chambers RA, Taylor JR, Potenza MN (2003) Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 160:1041-1052
42. Chechik G, Meilijson I, Ruppin E (1999) Neuronal regulation: a mechanism for synaptic pruning during brain maturation. Neural Comput 11:2061-2080
43. Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, Keltner JR, Beal MF, Rosen BR, Jenkins BG (1997) Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn Reson Med 38:389-398
44. Christakou A, Robbins TW, Everitt BJ (2001) Functional disconnection of a prefrontal corticaldorsal striatal system disrupts choice reaction time performance: implications for attentional function. Behav Neurosci 115:812-825
45. Christakou A, Robbins TW, Everitt BJ (2004) Prefrontal cortical-ventral striatal interactions involved in affective modulation of attentional performance: implications for corticostriatal circuit function. J Neurosci 24:773-780
46. Chugani HT, Phelps ME, Mazziotta JC (1987) Positron emission tomography study of human brain functional development. Ann Neurol 22:487-497
47. Collins GB, Pippenger CE, Janesz JW (1984) Links in the chain: an approach to the treatment of drug abuse on a professional football team. Cleve Clin Q 51:485-92
48. Dalley JW, Cardinal RN, Robbins TW (2004) Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28:771-784
49. De Bellis MD, Keshavan MS, Beers SR, Hall J, Frustaci K, Masalehdan A, Noll J, Boring AM (2001) Sex differences in brain maturation during childhood and adolescence. Cereb Cortex 11:552-557
50. Dixon AL, Prior M, Morris PM, Shah YB, Joseph MH, Young AM (2005) Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48:236-245
51. Doremus-Fitzwater TL, Varlinskaya EI, Spear LP (2010) Motivational systems in adolescence: Possible implications for age differences in substance abuse and other risk-taking behaviors. Brain Cogn 72:114-123
52. Easton N, Shah YB, Marshall FH, Fone KC, Marsden CA (2006) Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast. Psychopharmacology (Berl) 189:369-385
53. Easton N, Marshall F, Fone K, Marsden C (2007) Atomoxetine produces changes in cortico-basal thalamic loop circuits: assessed by phMRI BOLD contrast. Neuropharmacology 52:812-826
54. Eshel N, Nelson EE, Blair RJ, Pine DS, Ernst M (2007) Neural substrates of choice selection in adults and adolescents: development of the ventrolateral prefrontal and anterior cingulate cortices. Neuropsychologia 45:1270-1279
55. Evenden JL (1999) Varieties of impulsivity. Psychopharmacology (Berl) 146:348-361
56. Evenden JL, Ryan CN(1996) The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl) 128:161-170
57. Fareri DS, Martin LN, Delgado MR (2008) Reward-related processing in the human brain: developmental considerations. Dev Psychopathol 20:1191-211
58. Febo M, Segarra AC, Nair G, Schmidt K, Duong TQ, Ferris CF (2005) The neural consequences of repeated cocaine exposure revealed by functional MRI in awake rats. Neuropsychopharmacology 30:936-943
59. Ferguson SA, Boctor SY (2010) Cocaine responsiveness or anhedonia in rats treated with methylphenidate during adolescence. Neurotoxicol Teratol 32:432-442
60. Fletcher PJ, Tenn CC, Sinyard J, Rizos Z, Kapur S (2007) A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Neuropsychopharmacology 32:1122-1132
61. Frahm J, Kruger G, Merboldt KD, Kleinschmidt A (1996) Dynamic uncoupling and recoupling of perfusion and oxidative metabolism during focal brain activation in man. Magn Reson Med 35:143-148
62. Gadian DG (1995) NMR and its applications to living systems. Oxford University Press, Oxford
63. Giedd JN (2008) The teen brain: insights from neuroimaging. J Adolesc Health 42:335-343
64. Guscott M, Bristow LJ, Hadingham K, Rosahl TW, Beer MS, Stanton JA, Bromidge F, Owens AP, Huscroft I, Myers J, Rupniak NM, Patel S, Whiting PJ, Hutson PH, Fone KC, Biello SM, Kulagowski JJ, McAllister G (2005) Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 48:492-502
65. Harel N, Lee SP, Nagaoka T, Kim DS, Kim SG (2002) Origin of negative blood oxygenation leveldependent fMRI signals. J Cereb Blood Flow Metab 22:908-917
66. Hastjarjo T, Silberberg A, Hursh SR (1990) Risky choice as a function of amount and variance in food supply. J Exp Anal Behav 53:155-61
67. Hechtman L, Greenfield B (2003) Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome. Paediatr Drugs 5:787-794
68. Herpertz SC, Sass H (2000) Emotional deficiency and psychopathy. Behav Sci Law 18:567-580
69. Hewitt KN, Shah YB, Prior MJ, Morris PG, Hollis CP, Fone KC, Marsden CA (2005) Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder. Psychopharmacology (Berl) 180:716-723
70. Ikemoto S, Panksepp J (1999) The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Rev 31:6-41
71. Kallman WM, Isaac W (1975) The effects of age and illumination on the dose-response curves for three stimulants. Psychopharmacologia 40:313-318
72. Kalsbeek A, Voorn P, Buijs RM, Pool CW, Uylings HB (1988) Development of the dopaminergic innervation in the prefrontal cortex of the rat. J Comp Neurol 269:58-72
73. Kaminski BJ, Ator NA (2001) Behavioral and pharmacological variables affecting risky choice in rats. J Exp Anal Behav 75:275-97
74. Kellogg CK, Awatramani GB, Piekut DT (1998) Adolescent development alters stressor-induced Fos immunoreactivity in rat brain. Neuroscience 83:681-689
75. Klein-Schwartz W, McGrath J (2003) Poison centers' experience with methylphenidate abuse in pre-teens and adolescents. J Am Acad Child Adolesc Psychiatry 42:288-94
76. Laviola G, Wood RD, Kuhn C, Francis R, Spear LP (1995) Cocaine sensitization in periadolescent and adult rats. J Pharmacol Exp Ther 275:345-357
77. Laviola G, Adriani W, Terranova ML, Gerra G (1999) Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models. Neurosci Biobehav Rev 23:993-1010
78. Laviola G, Macri S, Morley-Fletcher S, AdrianiW(2003) Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci Biobehav Rev 27:19-31
79. Lebel C, Walker L, Leemans A, Phillips L, Beaulieu C (2008) Microstructural maturation of the human brain from childhood to adulthood. NeuroImage 40:1044-1055
80. Lenroot RK, Giedd JN (2006) Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neurosci Biobehav Rev 30:718-729
81. Leo D, Adriani W, Cavaliere C, Cirillo G, Marco EM, Romano E, di Porzio U, Papa M, Perrone- Capano C, Laviola G (2009) Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology. Genes Brain Behav 8:356-68
82. Levin FR, Kleber HD (1995) Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harvard Rev Psychiatry 2:246-258
83. Levy F, Swanson JM (2001) Timing, space and ADHD: the dopamine theory revisited. Aust N Z J Psychiatry 35:504-511
84. Lidow MS, Goldman-Rakic PS, Rakic P (1991) Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proc Natl Acad Sci U S A 88:10218-10221
85. Lockwood CA, Menter CG, Moggi-Cecchi J, Keyser AW (2007) Extended male growth in a fossil hominin species. Science 318:1443-1446
86. Marco EM, Adriani W, Ruocco LA, Canese R, Sadile AG, Laviola G (2011) Neurobehavioral adaptations to methylphenidate: the issue of early adolescent exposure. Neurosci Biobehav Rev 35:1722-39
87. Marota JJ, Mandeville JB, Weisskoff RM, Moskowitz MA, Rosen BR, Kosofsky BE (2000) Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in Rat. NeuroImage 11:13-23
88. McCabe SE, Teter CJ, Boyd CJ, Guthrie SK (2004) Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. J Adolesc Health 35:501-504
89. Meaney MJ, Stewart J (1981) Neonatal-androgens influence the social play of prepubescent rats. Horm Behav 15:197-213
90. Mobini S, Chiang TJ, Ho MY, Bradshaw CM, Szabadi E (2000) Effects of central 5-hydroxytryptamine depletion on sensitivity to delayed and probabilistic reinforcement. Psychopharmacology (Berl) 152:390-397
91. Morrissey G, Wogar MA, Bradshaw CM, Szabadi E (1993) Effect of lesions of the ascending 5-hydroxytryptaminergic pathways on timing behaviour investigated with an interval bisection task. Psychopharmacology (Berl) 112:80-85
92. Muramoto S, Yamada H, Sadato N, Kimura H, Konishi Y, Kimura K, Tanaka M, Kochiyama T, Yonekura Y, Ito H (2002) Age-dependent change in metabolic response to photic stimulation of the primary visual cortex in infants: functional magnetic resonance imaging study. J Comput Assist Tomogr 26:894-901
93. Nemoda Z, Szekely A, Sasvari-Szekely M (2011) Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. Neurosci Biobehav Rev 35:1665-86
94. Nightingale EO, Fischhoff B (2002) Adolescent risk and vulnerability: overview. J Adolesc Health 31:3-9
95. Panksepp J (1981) The ontogeny of play in rats. Dev Psychobiol 14:327-332
96. Park F (2007) Lentiviral vectors: are they the future of animal transgenesis? Physiol Genomics 31:159-173
97. Patrick KS, Markowitz JS (1997) Pharmacology of methylphenidate, amphetamine enantiomers, and penoline in attention deficit/hyperactivity disorder. Hum Psychopharmacol 12:527-546
98. Paus T, Zijdenbos A, Worsley K, Collins DL, Blumenthal J, Giedd JN, Rapoport JL, Evans AC (1999) Structural maturation of neural pathways in children and adolescents: in vivo study. Science 283:1908-1911
99. Preece MA, Sibson NR, Raley JM, Blamire A, Styles P, Sharp T (2007) Region-specific effects of a tyrosine-free amino acid mixture on amphetamine-induced changes in BOLD fMRI signal in the rat brain. Synapse 61:925-932
100. Ptacek R, Kuzelova H, Paclt I, Zukov I, Fischer S (2009) ADHD and growth: anthropometric changes in medicated and non-medicated ADHD boys. Med Sci Monit 15:CR595-599
101. Puumala T, Ruotsalainen S, Jakala P, Koivisto E, Riekkinen P Jr, Sirvio J (1996) Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder. Neurobiol Learn Mem 66:198-211
102. Ragozzino ME (2003) Acetylcholine actions in the dorsomedial striatum support the flexible shifting of response patterns. Neurobiol Learn Mem 80:257-267
103. RebecGV, Christiansen JRC, GuerraC, BardoMT (1997a)Regional and temporal differences in realtime dopamine efflux in the nucleus accumbens during free-choice novelty. Brain Res 776:61-67
104. Rebec GV, Grabner CP, Johnson M, Pierce RC, Bardo MT (1997b) Transient increases in cathecolaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty. Neuroscience 76:707-714
105. Rogers RD, Baunez C, Everitt BJ, Robbins TW (2001) Lesions of the medial and lateral striatum in the rat produce differential deficits in attentional performance. Behav Neurosci 115:799-811
106. Romani C, Adriani W, Manciocco A, Vitale A, Laviola G (2010) Evaluation of impulsive behaviour in Callithrix jacchus: a pilot study. In: Abstract Book, V European Conference on Behavioural Biology (ECBB) , Ferrara, Italy, July 15-18, p 126
107. Rother J, Knab R, Hamzei F, Fiehler J, Reichenbach JR, Buchel C, Weiller C (2002) Negative dip in BOLD fMRI is caused by blood flow-oxygen consumption uncoupling in humans. NeuroImage 15:98-102
108. Sadile AG, Pellicano MP, Sagvolden T, Sergeant JA (1996) NMDA and non-NMDA sensitive [L-3H]glutamate receptor binding in the brain of the Naples high-and low-excitability rats: an autoradiographic study. Behav Brain Res 78:163-174
109. Sagvolden T, Pettersen MB, Larsen MC (1993) Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains. Physiol Behav 54:1047-1055
110. Salamone JD, CorreaM (2002) Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav Brain Res 137:3-25
111. Salamone JD, Correa M, Mingote SM, Weber SM (2005) Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr Opin Pharmacol 5:34-41
112. Scheffler RM, Hinshaw SP, Modrek S, Levine P (2007) The global market for ADHD medications. Health Aff (Millwood) 26:450-457
113. Schepis TS, Adinoff B, Rao U (2008) Neurobiological processes in adolescent addictive disorders. Am J Addict 17:6-23
114. Schmithorst VJ, Yuan W (2010) White matter development during adolescence as shown by diffusion MRI. Brain Cogn 72:16-25
115. Seeman P, Madras BK (1998) Anti-hyperactivity medication: methylphenidate & amphetamine. Mol Psychiatry 3:386-396
116. Self DW (2004) Regulation of drug-taking and-seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 47:242-255
117. Shen RY, Choong KC (2006) Different adaptation in ventral tegmental dopamine neurons in control vs ethanol exposed rats after methylphenidate treatment. Biol Psychiatry 59:635-642
118. Shmuel A, Augath M, Oeltermann A, Logothetis NK (2006) Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1. Nat Neurosci 9:569-577
119. Sicard KM, Duong TQ (2005) Effects of hypoxia, hyperoxia, and hypercapnia on baseline and stimulus-evoked BOLD, CBF, and CMRO2 in spontaneously breathing animals. NeuroImage 25:850-858
120. Sonuga-Barke EJ (2005) Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry 57:1231-1238
121. Sowell ER, Delis D, Stiles J, Jernigan TL (2001) Improved memory functioning and frontal lobe maturation between childhood and adolescence: a structural MRI study. J Int Neuropsychol Soc 7:312-322
122. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW (2003) Mapping cortical change across the human life span. Nat Neurosci 6:309-315
123. Spear LP (2000) The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417-463
124. Spear LP, Brake SC (1983) Periadolescence: age-dependent behavior and psycho-pharmacological responsivity in rats. Dev Psychobiol 16:83-109
125. Stamford JA (1989) Development and ageing of the rat nigrostriatal dopamine system studied with fast cyclic voltammetry. J Neurochem 52:1582-1589
126. Stephens DW, Anderson D (2001) The adaptive value of preference for immediacy: when shortsighted rules have farsighted consequences. Behav Ecol 12:330-339
127. Svetlov SI, Kobeissy FH, Gold MS (2007) Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine. J Addict Dis 26:1-6
128. Tarazi FI, Tomasini EC, Baldessarini RJ (1998) Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors. Brain Res 110:227-233
129. Tarazi FI, Tomasini EC, Baldessarini RJ (1999) Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: An autoradiographic study. Dev Neurosci 21:43-49
130. Teicher MH, Andersen SL, Hostetter JC Jr (1995) Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Brain Res 89:167-172
131. Terranova ML, Laviola G, Alleva E (1993) Ontogeny of amicable social behavior in the mouse: gender differences and ongoing isolation outcomes. Dev Psychobiol 26:467-481
132. Terranova ML, Laviola G, de Acetis L, Alleva E (1998) A description of the ontogeny of mouse agonistic behavior. J Comp Psychol 112:3-12
133. Tirelli E, Laviola G, Adriani W (2003) Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents. Neurosci Biobehav Rev 27:163-178
134. Vendruscolo LF, Izídio GS, Takahashi RN, Ramos A (2008) Chronic methylphenidate treatment during adolescence increases anxiety-related behaviors and ethanol drinking in adult spontaneously hypertensive rats. Behav Pharmacol 19:21-27
135. Volkow ND, Swanson JM (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 160:1909-18
136. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Dewey SL, Hitzemann R, Gifford AN, Pappas NR (1999) Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high". J Pharmacol Exp Ther 288:14-20
137. Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A, Franceschi D (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21:RC121
138. Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM (2002) Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 43:181-187
139. White FJ, Kalivas PW (1998) Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 51:141-153
140. Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S (2008) Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 47:21-31
141. Wills TA, Vaccaro D, McNamara G (1994) Novelty seeking, risk taking, and related constructs as predictors of adolescent substance use: an application of Cloninger's theory. J Subst Abuse 6:1-20
142. Wills TA, Sandy JM, Shinar O (1999) Cloninger's constructs related to substance use level and problems in late adolescence: a mediational model based on self-control and coping motives. Exp Clin Psychopharmacol 7:122-134
143. Wogar MA, Bradshaw CM, Szabadi E (1993) Does the effect of central 5-hydroxytryptamine depletion on timing depend on motivational change? Psychopharmacology (Berl) 112:86-92
144. Wolf ME, Sun X, Mangiavacchi S, Chao SZ (2004) Psychomotor stimulants and neuronal plasticity. Neuropharmacology 47:61-79
145. Yano M, Steiner H (2005) Methylphenidate (Ritalin) induces Homer1a and zif268 expression in specific corticostriatal circuits. Neuroscience 132:855-865
146. Yano M, Steiner H (2007) Methylphenidate and cocaine: the same effects on gene regulation? Trends Pharmacol Sci 28:588-596
147. Yin HH, Knowlton BJ, Balleine BW (2004) Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur J Neurosci 19:181-189
148. Zuckerman M (1984) Sensation seeking: a comparative approach to a human trait. Behav Brain Sci 7:413-471